Intranasal Oxytocin for Autism Spectrum Disorder and Comorbid Severe Intellectual Disabilities:Open-label long term study

Not Applicable

• Conditions: Autism Spectrum Disorder Severe intellectual disabilities

• Registration Number: JPRN-UMIN000028650
• Lead Sponsor: ational Hospital Organization Hizen Psychiatric Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-09-01
• Study Completion: 2019-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

Not provided

Exclusion Criteria

CARS-TV less than 30 points self-standing position impossible Weight under 20kg History of status epilepticus possibility of pregnancy Physical exhaustion and advanced inspection value or more

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
After 24 weeks administration of intranasal Oxytocin The Japanese version of the RBS-R(Repetitive Behavior Scale-Revised)(Stereotyped,Self-injurious)

Secondary Outcome Measures

Name	Time	Method
The Japanese version of the RBS-R(Repetitive Behavior Scale-Revised)(Compulsive,Ritualistic,Sameness,Restricted interests) The Japanese Version of the Abberrant Behavior Checklist(Illitability) The Japanese version of the Sensory Profile Short Version CGI-S CGI-I Plasma oxytocin,salivary oxytocin